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A B S T R A C T
The “Evidence-based Telemedicine - Trauma & Acute Care Surgery” (EBT-TACS) Journal Club conducted a critical review of the
literature and selected three recent studies on the use of corticosteroids for the prophylaxis of fat embolism syndrome (FES). The
review focused on the potential role of corticosteroids administration to patients admitted to the intensive care unit (ICU) at risk of
developing post-traumatic fat embolism. The first study was prospective and aimed at identifying reliable predictors, which could be
detected early and were associated with the onset of fat embolism syndrome in trauma patients. The second manuscript was a
literature review on the role of corticosteroids as a prophylactic measure for FES. The last manuscript was a meta-analysis on the
potential for corticosteroids to prophylactically reduce the risk of fat embolism syndrome in patients with long bone fractures. The
main conclusions and recommendations reached were that traumatized patients should be monitored with non-invasive pulse
oximetry and lactate levels since these commonly-available tests may predict the development of FES, and the lack of evidence to
recommend the use of steroids for the prophylaxis of this syndrome.
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INTRODUCTION
Fat embolism syndrome (FES) is common in patients withlong bone fractures and can be fatal. Delayed diagnosis
of this syndrome increases the risk of devastating
consequences1-4. For this reason FES should be considered
and treated early 5.
The use of corticosteroids in FES has been
proposed in numerous small clinical trials, but its
recommendation remains controversial1.
The participants of the “Evidence-based
Telemedicine - Trauma & Acute Care Surgery” (EBT-TACS)
Journal Club, after reviewing the literature on this topic,
selected three articles that address important questions
about  the use of  corticosteroids for the prevention of
FES:  1) the existence of markers capable of predicting
the development of FES, which could be used in clinical
practice and lead prophylactic measures for FES; 2) the
recommendation for the use of corticosteroids in the
prevention of  FES1-3.
STUDY 1
“Early, reliable, utilitarian predictive factors for
fat embolism syndrome in polytrauma patients”1
Background
Fat embolism syndrome (FES) is a very serious
condition and delayed diagnosis may have serious
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consequences. Therefore predictors can be very useful in
guiding prevention and treatment.
Question
Are there reliable and useful predictors that early,
reliably and economically predict the development of FES
in trauma patients?
Main findings of this study
There is a correlation between admission serum
lactate levels (> 22 mmol / l), FES (p = 0.07) and hypoxemia
(p = 0.003).
Continuous noninvasive pulse oximetry during the
first 72 hours in the ICU is associated with the onset of
pulmonary complications. There is a correlation (100%
sensitivity) between at least one episode of desaturation
during the first 24 hours and the development of FES.
In this study, the increase in the serum lactate
levels (> 22 mmol / l) and episode(s) of hypoxemia, even
when transient, were associated with an increased chance
of developing FES (p < 0:02).
Strengths
1. The topic is current and clinically relevant in
view of the growing number of patients victims of high-
energy trauma;
2 . Analyzed routinely measured parameters that
require little change in care routine;
3 . Low cost of detection suggested by the study.
Limitations
1. Included a small number of patients (n=67).
2 . Exclusion criteria for the analysis meant
common conditions such abdominal trauma, brain and
thoracic injury were disregarded, thus limiting the
generalizability of the findings.
3 . It is unclear whether patients were uniformily
treated, i.e. time interval for fracture fixation, allowing for the
interpretation that these parameters may have affected the
outcome of patients, increasing the risk of developing FES.
STUDY 2
“Role of corticosteroids as a prophylactic measure
in fat embolism syndrome: review of the literature”2
Background
FES is a serious condition in trauma patients with
fractures of the lower limbs, and it is not yet clear whether
corticosteroids should be used as a prophylactic measure
for this syndrome.
Question
What is the real role of corticosteroids in the
prophylaxis of FES?
Main findings of this study
This study analyzes seven clinical trials that
included 483 patients: 223 patients prophylactically treated
with corticosteroids and 260 not (control group). Of the
total, 9 patients in the group receiving corticosteroids
developed FES versus 60 in the control group, resulting in a
statistically significant difference (p < 0.05).
Strengths
1. Clinical trials whose designs prioritized equal
distribution between the intervention and control groups,
according to severityof the injuries.
2. The study designs included an analysis of
possible adverse effects and complications from the use of
corticosteroids.
3. Low cost medication, easy access and
management.
4. Easily reproducible results
Limitations
1. Lack of uniformity in the diagnostic criteria for
FES among the different studies.
2. The majority of the studies were old, making
it difficult to make a comparative analysis with the current
critical care of patients.
3. Large differences in the dose and interval of
corticosteroids in the various studies.
4. Despite statistically significant use of
corticosteroids for the prophylaxis of FES, the studies do not
provide evidence about the actual role of the medication.
5. Small number of patients included in the
analysis.
STUDY 3
“Do corticosteroids reduce the risk of fat
embolism syndrome in patients with long bone fractures?
A meta-analysis”3
Background
The incidence of fat embolism in patients with
long bone and pelvis fractures is high, exceeding 80%.
The cases of FES represent up to 33% of cases of patients
with bilateral femur fractures, with mortality rates ranging
from 5 to 20%. This justifies finding a treatment that
prevents the appearance of FES.
Question
Based on available studies, is there evidence that
the use of corticosteroids in trauma patients with long bone
fractures reduces the risk of FES?
Main findings of this study
The manuscript is a meta-analysis of several
English language and non-English language studies that
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were published from 1966 to 2006 using the MEDLINE,
EMBASE, HealthSTAR, CINAHL and Cochrane research
databases, related to the subject of active research,
and of papers in orthopedic magazines, as well as
orthopedic conference proceedings and orthopedic
textbooks.
104 studies related to the topic were found, of
which seven met the criteria of being randomized or semi-
randomized studies on the use of corticosteroids for the
prevention of FES in patients with  fractures of at least one
long bone. The, patients were divided into receiving the
treatment and control group (no prophylaxis).
Combined analysis of studies included 389
patients, and found that corticosteroids reduced the risk of
FES in 78% (relative risk [RR] 0.22).
There was a 61% reduction of the risk of hypoxia,
with no influence on the appearance of petechial rash or
on overall mortality.
Using a sensitivity analysis, it was concluded that
low-dose corticosteroids (methylprednisolone 6 mg/kg for
48 h in 6 divided doses) would be more effective than higher
doses.
The use of corticosteroids was not associated with
an increased incidence of infection.
Strengths
1- A meta-analysis with extensive review of
English and non-English language literature was conducted.
2- Randomized studies were selected and two
were considered quasi-randomized by alternate sequence
selection.
3- The studies were selected by experts blinded
to the origin of the study and patient outcome. The reviewers
were also blinded to origin and outcome.
4- The quality of the articles was determined
using a score of 21 points, which were converted into gra-
des ranging from 0 to 100, the higher the score, the better
the quality.
Limitations
1 - With the exception of a 2004 article, the other
six studies were more than 20 years old6-8.
2 - The number of patients included in this meta-
analysis was small (389), which was split into two groups
and originating from few prospective and randomized
studies.
3 - The grades used to measure the quality of
evaluated articles ranged from 24 to 74, according to the
authors themselves.
4 - Although this meta-analysis came up with a
result largely supporting the use of corticosteroids, the
authors suggest that other non-measured variables, which
could influence the outcome, were not included. Non-
measured variables include the more recent changes in
the standards of care, such as earlier fixation of fractures,
protective ventilation with lower tidal volumes and the
similarity in the clinical diagnosis of SIRS and FES may have
over the course of time that these studies span, confounded
the results, leading to false conclusions.
CONCLUSIONS
FES is a serious complication that occurs in trau-
ma patients, and the standardization of care in order to
achieve early detection of this condition may represent a
fundamental aspect of the proper therapeutic approach to
these patients. The non-invasive monitoring using continuous
pulse oximetry, as well as an elevated serum lactate had a
good correlation with increased risk of developing FES.
The use of corticosteroids as a prophylactic
measure has been recommended by the available clinical
trials. However, this recommendation is not without
controversy, mainly due to significant differences among
the designs of the clinical trials, as well as the lack of
uniformity in diagnostic parameters and the interval / dosage
of corticosteroid used.
RECOMMENDATIONS
Recommendations for the treatment of trauma
patients at risk for development of FES are:
1. Continuous monitoring, using noninvasive pulse
oximetry.
2. Admission serum lactate levels.
3. Conducting further clinical trials with
standardization of diagnostic and therapeutic parameters
for an adequate analysis of the evidence.
4. There is still not enough evidence to
recommend the use of prophylactic corticosteroids in
patients with long bone fractures.
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R E S U M O
A reunião de revista “Telemedicina Baseada em Evidência - Cirurgia do Trauma e Emergência” (TBE-CiTE) realizou uma revisão
crítica da literatura e selecionou três artigos recentes sobre o uso de corticoide para a profilaxia da síndrome de embolia gordurosa.
O foco desta revisão foi a indicação ou não do uso de corticoide nos pacientes admitidos na unidade de terapia intensiva (UTI) com
risco de desenvolverem embolia gordurosa pós traumática. O primeiro artigo foi um estudo prospectivo com o objetivo de estabe-
lecer fatores preditivos confiáveis, precoces e úteis associados ao aparecimento da síndrome da embolia gordurosa (SEG) em
pacientes traumatizados. O segundo artigo foi uma revisão de literatura sobre o papel do corticoide como medida profilática à
síndrome de embolia gordurosa. O último artigo foi uma meta-análise sobre a capacidade do corticoide em reduzir o risco de
síndrome da embolia gordurosa nos pacientes com fraturas de ossos longos. As principais conclusões e recomendações foram que
pacientes traumatizados devem ser monitorizados na UTI com oximetria de pulso e medida do lactato já que estes fatores podem
predizer o aparecimento de SEG e que não existe evidência suficiente para recomendar o uso de corticoide para a profilaxia desta
síndrome.
Descritores: Corticosteroides. Prevenção primária. Embolia gordurosa. Pacientes. Fraturas ósseas.
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